A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893) - Willemzen, Rein; Suciu, S.; Archimbaud, E.; Muus, P.; Stryckmans, P.; Louwagie, E. A.; Berneman, Z.; Tjean, M.; Wijermans, P.; Döhner, Hartmut; Jehn, U.; Labar, B.; et al. (Leukemia, 1997)
Gesehen am 31.10.2024